EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES CARDIAC DEVELOPMENTAL GENE PATTERNING AND A NOVEL CLASS OF BIOMARKERS FOR HEART FAILURE

摘要

The present invention relates to a method of determining markers for a disease from a patient, wherein information from epigenomics and/or the transcriptome from peripheral blood and a diseased tissue or information from epigenomics and the transcriptome from peripheral blood or a diseased tissue is used for obtaining the markers, as well as a method of determining a risk for a disease in a patient using the markers obtained thereby.